-
1
-
-
0035799806
-
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
-
PMID: 11333990
-
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-50. [PMID: 11333990]
-
(2001)
N Engl J Med
, vol.344
, pp. 1343-1350
-
-
Tuomilehto, J.1
Lindstrom, J.2
Eriksson, J.G.3
Valle, T.T.4
Hamalainen, H.5
Ilanne-Parikka, P.6
-
2
-
-
0037034257
-
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
PMID: 11832527
-
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. [PMID: 11832527]
-
(2002)
N Engl J Med
, vol.346
, pp. 393-403
-
-
Knowler, W.C.1
Barrett-Connor, E.2
Fowler, S.E.3
Hamman, R.F.4
Lachin, J.M.5
Walker, E.A.6
-
3
-
-
0037097039
-
Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM ran-domised trial
-
PMID: 12086760
-
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM ran-domised trial. Lancet. 2002;359:2072-7. [PMID: 12086760]
-
(2002)
Lancet
, vol.359
, pp. 2072-2077
-
-
Chiasson, J.L.1
Josse, R.G.2
Gomis, R.3
Hanefeld, M.4
Karasik, A.5
Laakso, M.6
-
4
-
-
0036724346
-
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
-
PMID: 12196473
-
Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 2002;51:2796-803. [PMID: 12196473]
-
(2002)
Diabetes
, vol.51
, pp. 2796-2803
-
-
Buchanan, T.A.1
Xiang, A.H.2
Peters, R.K.3
Kjos, S.L.4
Marroquin, A.5
Goico, J.6
-
5
-
-
0037806845
-
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program
-
PMID: 12502656
-
Herman WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care. 2003;26:36-47. [PMID: 12502656]
-
(2003)
Diabetes Care
, vol.26
, pp. 36-47
-
-
Herman, W.H.1
Brandle, M.2
Zhang, P.3
Williamson, D.F.4
Matulik, M.J.5
Ratner, R.E.6
-
6
-
-
20044395091
-
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
-
PMID: 15738451
-
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142: 323-32. [PMID: 15738451]
-
(2005)
Ann Intern Med
, vol.142
, pp. 323-332
-
-
Herman, W.H.1
Hoerger, T.J.2
Brandle, M.3
Hicks, K.4
Sorensen, S.5
Zhang, P.6
-
7
-
-
0036399171
-
Archimedes: A new model for simulating health care systems-the mathematical formulation
-
PMID: 12415725
-
Schlessinger L, Eddy DM. Archimedes: a new model for simulating health care systems-the mathematical formulation. J Biomed Inform. 2002;35:37-50. [PMID: 12415725]
-
(2002)
J Biomed Inform
, vol.35
, pp. 37-50
-
-
Schlessinger, L.1
Eddy, D.M.2
-
8
-
-
0242300709
-
Archimedes: A trial-validated model of diabetes
-
PMID: 14578245
-
Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003;26:3093-101. [PMID: 14578245]
-
(2003)
Diabetes Care
, vol.26
, pp. 3093-3101
-
-
Eddy, D.M.1
Schlessinger, L.2
-
9
-
-
0242300707
-
Validation of the Archimedes diabetes model
-
PMID: 14578246
-
Eddy DM, Schlessinger L. Validation of the Archimedes diabetes model. Diabetes Care. 2003;26:3102-10. [PMID: 14578246]
-
(2003)
Diabetes Care
, vol.26
, pp. 3102-3110
-
-
Eddy, D.M.1
Schlessinger, L.2
-
10
-
-
33645187410
-
Equations for the Archimedes model of diabetes and its complications
-
Schlessinger L, Eddy DM. Equations for the Archimedes model of diabetes and its complications. Technical Report, Parts A and B. 2004. Accessed at http://archimedesmodel.com.
-
(2004)
Technical Report, Parts a and B
-
-
Schlessinger, L.1
Eddy, D.M.2
-
11
-
-
0034631870
-
Exercise and weight loss reduce blood pressure in men and women with mild hypertension: Effects on cardiovascular, metabolic, and hemodynamic functioning
-
PMID: 10888969
-
Blumenthal JA, Sherwood A, Gullette EC, Babyak M, Waugh R, Georgiades A, et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: effects on cardiovascular, metabolic, and hemodynamic functioning. Arch Intern Med. 2000;160:1947-58. [PMID: 10888969]
-
(2000)
Arch Intern Med
, vol.160
, pp. 1947-1958
-
-
Blumenthal, J.A.1
Sherwood, A.2
Gullette, E.C.3
Babyak, M.4
Waugh, R.5
Georgiades, A.6
-
12
-
-
0023232216
-
Helsinki Heart Study: Primary-prevention trial with gemnbrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
PMID: 3313041
-
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al. Helsinki Heart Study: primary-prevention trial with gemnbrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317:1237-45. [PMID: 3313041]
-
(1987)
N Engl J Med
, vol.317
, pp. 1237-1245
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
Heinonen, O.P.4
Heinsalmi, P.5
Helo, P.6
-
13
-
-
0029099086
-
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
-
The Multicenter Metformin Study Group. [PMID: 7623902]
-
DeFronzo RA, Goodman AM. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med. 1995;333:541-9. [PMID: 7623902]
-
(1995)
N Engl J Med
, vol.333
, pp. 541-549
-
-
DeFronzo, R.A.1
Goodman, A.M.2
-
15
-
-
0042035609
-
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes
-
PMID: 12941712
-
Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care. 2003;26:2518-23. [PMID: 12941712]
-
(2003)
Diabetes Care
, vol.26
, pp. 2518-2523
-
-
-
16
-
-
0242483252
-
Valuing health-related quality of life in diabetes
-
PMID: 12453967
-
Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, et al. Valuing health-related quality of life in diabetes. Diabetes Care. 2002;25:2238-43. [PMID: 12453967]
-
(2002)
Diabetes Care
, vol.25
, pp. 2238-2243
-
-
Coffey, J.T.1
Brandle, M.2
Zhou, H.3
Marriott, D.4
Burke, R.5
Tabaei, B.P.6
-
17
-
-
1842334456
-
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
-
PMID: 9203460
-
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97. [PMID: 9203460]
-
(1997)
Diabetes Care
, vol.20
, pp. 1183-1197
-
-
-
18
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK Prospective Diabetes Study (UKPDS) Group. [PMID: 9742976]
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837-53. [PMID: 9742976]
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
19
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group. [PMID: 8366922]
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86. [PMID: 8366922]
-
(1993)
N Engl J Med.
, vol.329
, pp. 977-986
-
-
-
20
-
-
0035922444
-
The effect of itbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
PMID: 11565519
-
Parving HH, Lehnen H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P, et al. The effect of itbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870-8. [PMID: 11565519]
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.H.1
Lehnen, H.2
Brochner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Arner, P.6
-
21
-
-
0037031094
-
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
PMID: 12114037
-
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33. [PMID: 12114037]
-
(2002)
Lancet
, vol.360
, pp. 23-33
-
-
-
22
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
-
The Heart Outcomes Prevention Evaluation Study Investigators. [PMID: 10639539]
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53. [PMID: 10639539]
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
23
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
-
Heart Outcomes Prevention Evaluation Study Investigators. [PMID: 10675071]
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355: 253-9. [PMID: 10675071]
-
(2000)
Lancet
, vol.355
, pp. 253-259
-
-
-
24
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
-
Cholesterol and Recurrent Events Trial investigators. [PMID: 8801446]
-
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-9. [PMID: 8801446]
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
Rouleau, J.L.4
Rutherford, J.D.5
Cole, T.G.6
-
25
-
-
0027517659
-
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
-
The Collaborative Study Group. [PMID: 8413456]
-
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993;329:l456-62. [PMID: 8413456]
-
(1993)
N Engl J Med
, vol.329
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Bain, R.P.3
Rohde, R.D.4
-
26
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
PMID: 11565517
-
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-60. [PMID: 11565517]
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
Berl, T.4
Pohl, M.A.5
Lewis, J.B.6
-
27
-
-
14444271787
-
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial
-
PMID: 9841599
-
Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med. 1998;129:681-9. [PMID: 9841599]
-
(1998)
Ann Intern Med
, vol.129
, pp. 681-689
-
-
Lewis, S.J.1
Moye, L.A.2
Sacks, F.M.3
Johnstone, D.E.4
Timmis, G.5
Mitchell, J.6
-
28
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
-
The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. [PMID: 9841303]
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-57. [PMID: 9841303]
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
29
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
-
SHEP Cooperative Research Group. [PMID: 2046107]
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991; 265:3255-64. [PMID: 2046107]
-
(1991)
JAMA
, vol.265
, pp. 3255-3264
-
-
-
30
-
-
0021350001
-
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
-
PMID: 6361299
-
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351-64. [PMID: 6361299]
-
(1984)
JAMA
, vol.251
, pp. 351-364
-
-
-
31
-
-
0021863832
-
MRC trial of treatment of mild hypertension: Principal results
-
Medical Research Council Working Party. [PMID: 2861880]
-
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed). 1985;291:97-104. [PMID: 2861880]
-
(1985)
Br Med J (Clin Res Ed)
, vol.291
, pp. 97-104
-
-
Results, P.1
-
32
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercho-lesterolemia
-
West of Scotland Coronary Prevention Study Group. [PMID: 7566020]
-
Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercho-lesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-7. [PMID: 7566020]
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
Isles, C.G.4
Lorimer, A.R.5
MacFarlane, P.W.6
-
33
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
PMID: 7968073
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344: 1383-9. [PMID: 7968073]
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
34
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-conttolled trial
-
PMID: 15325833
-
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-conttolled trial. Lancet. 2004;364: 685-96. [PMID: 15325833]
-
(2004)
Lancet
, vol.364
, pp. 685-696
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.5
Livingstone, S.J.6
-
35
-
-
1842863550
-
The Diabetes Prevention Program (DPP): Description of lifestyle intervention
-
PMID: 12453955
-
The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165-71. [PMID: 12453955]
-
(2002)
Diabetes Care
, vol.25
, pp. 2165-2171
-
-
-
36
-
-
0042532283
-
Estimated number of adults with prediabetes in the US in 2000: Opportunities for prevention
-
PMID: 12610015
-
Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care. 2003;26:645-9. [PMID: 12610015]
-
(2003)
Diabetes Care
, vol.26
, pp. 645-649
-
-
Benjamin, S.M.1
Valdez, R.2
Geiss, L.S.3
Rolka, D.B.4
Narayan, K.M.5
|